Introduction
According to the Center for Disease Control’s Autism and Developmental Disabilities Monitoring (ADDM) Network, an estimated 1 in 54 children have been diagnosed with Autism Spectrum Disorder (ASD) (1). The criteria used to identify such children is consistent with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and includes such traits as “persistent deficits in social communication and social interaction across multiple contexts” as well as “the presence of restricted, repetitive patterns of behavior, interests, or activities” (2). Among the factors that may complicate the clinical picture of a child exhibiting such traits include the possibility of a comorbid psychiatric condition. Indeed, individuals with ASD are at greater risk of experiencing one or more co-occurring psychiatric conditions compared to the general population (3). Furthermore, the presence of a comorbid psychiatric condition can complicate the clinical picture of an individual’s presentation with ASD through “symptom overlap, diagnostic overshadowing, and ambiguous symptom presentation in ASD” (3). A better understanding of how ASD co-presents with other psychiatric disorders can aid in more effective diagnostic approaches.
Just as individuals with ASD have a greater risk of having a co-morbid psychiatric condition, this increased risk extends specifically to co-occurring Schizophrenia Spectrum Disorders (SSD) (4). Conversely, children that demonstrate childhood-onset schizophrenia have been shown to be at greater risk for a history of premorbid ASD (5). These correlations provide evidence for a connection between these two psychiatric disorders, whether of a genetic, environmental, congenital, or other type of origin. However, this connection can pose challenges for diagnostic evaluation because these two diagnoses may be confused. This is at least partly owed to how the symptoms of one may be confused with those that are characteristic of the other, for example, ‘idiosyncratic beliefs’ in ASD vs delusions in psychosis (4). For this reason, it has been proposed, as by Cochran in 2013 (6), that “consideration of comorbid ASD and SSD should be given whenever there is a concern for psychotic symptoms that are accompanied by a change from baseline presentation in individuals with ASDs.”
This case report seeks to illustrate additional factors that may further complicate the diagnostic evaluation of an individual found to have comorbid ASD and a psychotic psychiatric disorder, such as SSD. In particular, this report not only displays by example how such comorbid psychiatric conditions pose challenges for the identification of either condition, but also how characteristics of parental interaction with the healthcare system can further compound these challenges. Additionally, this case highlights the importance of re-interpreting the results of past diagnostic testing as a way to combat these challenges.
Case report
The patient was a 16-year-old male from an Orthodox Jewish community with past medical history significant for obstructive sleep apnea, developmental speech delay, and recurrent otitis media, who presented to the Emergency Department with a worsening altered mental status over two weeks in 2020. Per parents, patient had been exhibiting paranoid delusions, rigidity, ‘strange behaviors,’ and agitation that precipitated trying to run away from home. Mental Status Exam was significant for inattentiveness, flat affect, delayed speech, and thought content containing paranoid delusions. Patient was restless, agitated, and avoiding eye contact with evaluators. He additionally appeared distressed when describing the feeling of a ‘bug’ crawling on his back which he believed was a ‘parasite’ inside him. Parents denied a history of seizures, auditory or visual hallucinations, headaches, and there were no focal neurological deficits.
History gleaned from parents reported that patient had frequently experienced such described ‘episodes’ of a similar psychosis since age eleven. During the first occurrence in 2015, parents found the patient outside after returning home from school, in a state of confusion. He subsequently exhibited bizarre behaviors such as refusing to respond when addressed, unwilling to eat/drink secondary to fear of ‘contamination,’ paranoid delusions, and religious fixations. He was subsequently taken to the hospital and admitted for evaluation that involved a primary work-up for metabolic and autoimmune encephalopathies. In the interim, he received a combination of antipsychotic and benzodiazepine for sedation and control of psychotic symptoms. Patient improved over the course of about a week, encephalopathies were ruled out, and the diagnostic focus shifted to primarily psychiatric etiologies. He received a diagnosis of Generalized Anxiety Disorder at the culmination of the first episode through evaluation by a psychiatrist by way of a consultation conducted during his stay, although it was not noted if this physician was a specialist in child and adolescent psychiatry.
Since that time in 2015, parents reported that about every four weeks the patient would become ‘difficult to manage’ or ‘out-of-control’ for about 5-7 days, with similar psychotic manifestations as the initial episode: religious fixations, limited speech, and obsessive-compulsive and paranoid tendencies surrounding food. During or directly following several such episodes, he was brought to the Emergency Department or out-patient office for evaluation, although no consistent identifiable triggers could be identified. Overall hospital course would remain similar with each encounter: receive antipsychotic and benzodiazepine medication, diagnostic evaluations to rule-out autoimmune or metabolic encephalopathies, then discharge with recommendation to further pursue psychiatric treatment. In each episode, the patient would be admitted under the neurological service, and it was unclear according to the available medical record how much, if at all, the patient was evaluated by the psychiatry service during each of his earlier admissions. Additionally, the available medical record did not demonstrate any occurrences of outpatient psychiatric evaluation, despite notes that this was often recommended upon discharges.
Beginning two years after the initial episode, parents stated that the patient intermittently displayed additional periods of apparent catatonia, where he would appear lethargic, low energy or ‘tired,’ be immobile, posturing, and lacking in spontaneous or responsive speech, with flat affect. Physician findings on physical exam of the patient in these states paralleled those reported by parents, while noting certain features classic of catatonia including echolalia and positive response to a lorazepam challenge.
At home, parents reported that patient would spontaneously return to ‘baseline’ in between episodes, without much help attributed to the variety of different treatments attempted over the years. During one documented encounter where parents were describing that the patient was exhibiting his ‘baseline’ behaviors, physician evaluation found him to be severely constricted, lacking spontaneous speech, with flat affect. Occasional incongruences were also noted between history provided by parents and documented medical records. In one example, the patient’s mother consistently stated that he had previously diagnosed autoimmune encephalitis, when this condition had been effectively ruled-out many times prior through extensive medical workups. She also stated that the patient had diagnosed Common Variable Immune Deficiency, when later a physician inquiry elicited that this was the result of her own interpretation of a test that she had ‘bought off of ebay.’ Nonetheless, these diagnoses were documented and maintained over time through the medical record, apparently based only on these oral reports.
Over the years, this patient received evaluations by a growing list of different primary care providers and specialists at a minimum of six different major healthcare facilities. During hospitalization, while concurrently pursuing diagnostic work-up, patient would receive medication for both sedation and management of psychosis or catatonia. Treatments pursued through the years (in addition to the combination of antipsychotic with benzodiazepine, often used only ‘as needed’ due to parental discord on treatment regimen) included antibiotics, high dose corticosteroids, standing escitalopram, and intravenous immunoglobulin (IVIG). However, each of these treatments failed to yield long-term remission. Regarding IVIG: the patient received many rounds since disease onset and his response varied from improvement, to no change, to even worsening. Meanwhile, the combination antipsychotic and benzodiazepine regimen, frequently employed during initial patient encounters and during inpatient stays, consistently yielded at least partial improvement in his symptoms. However, due to documented parental preference against long-standing use of these medications, these drugs were consistently discontinued after discharge, despite many physicians recommending their use long-term for at least empirical purposes.
Diagnostic focus and assessment
During the initial work-up during hospital visits and admission, autoimmune encephalitis was usually at the top of the differential diagnosis list. Taking into account characteristics that included the reported ‘relapsing-remitting’ course, the abruptness of symptom onset, and the patient’s age, and reported history of immunologic pathophysiology (CVID, prior episodes of ‘confirmed’ autoimmune encephalitis) a comprehensive work-up for autoimmune encephalitis was conducted many times over the years without any significant findings. Initially, basic labs were always drawn including Complete Blood Count (CBC) with differential, Comprehensive Metabolic Panel (including Liver Function Tests), Urine Toxicology Screen, Serum Drug screen – these always yielded nonsignificant results. Thereafter, more diagnostically focused testing was conducted for auto-immune encephalitis (Table 1). Additionally, potential triggering pathogens were investigated with antibody or polymerase chain reaction (PCT) testing, within serum and/or cerebrospinal fluid (Table 1). Most of these tests were repeated several times over the course of years during repeat evaluations, each time universally yielding nonsignificant findings. With these nonsignificant findings, coupled with consistently negative comprehensive neurological exams for focal deficits, the differential diagnosis always shifted towards psychiatrically-focused diagnoses, after ruling-out other rarer medical etiologies.
TABLE 1.
Diagnostic testing performed for investigation of autoimmune encephalitis
| Test | Source |
|---|---|
| vEEG with photic stimulation | N/A |
| Magnetic Resonance Imaging (MRI) | N/A |
| NDMA receptor antibody | Blood; CSF |
| Amino acid quantification | Blood; CSF |
| Bacterial culture, gram stain, glucose, protein, cell count | CSF |
| Immunoglobulin IgG index | Blood |
| Antinuclear antibody | Blood |
| Sjogren’s panel | Blood |
| Paraneoplastic panel | Blood |
| DNase antibody | Blood |
| Encephalopathy – autoimmune evaluation profile | Serum |
| Amino Acid Profile – quantitative | Blood; CSF |
| Antistreptolysin antibody | Blood |
| Pyruvate level | Blood; CSF |
| Lactate level | Blood; CSF |
| Enterovirus PCR | CSF |
| Varicella Zoster Virus – PCR | CSF |
| Herpes Simplex Virus – PCR | CSF |
| Lyme total antibody panel | CSF |
| Herpes Simplex Virus 1, 2 – IgG, IgM | CSF |
| Ebstein-Barr Virus – IgG, IgM | Blood |
| Lyme ELISA – IgG, IgM | Blood |
| Mycoplasma pneumonia – IgM | Blood |
| Mycoplasma pneumonia – PCR | Blood |
| Test | Source |
|---|---|
| Copper level – 24 hr | Urine |
| Copper level | Blood |
| Cerulosplasmin level | Blood |
| Acylcarnitine profile | Blood |
| Pentacarboxyporphyrin | Urine |
| Porphobilinogen | Urine |
| Homocysteine | Blood |
| Heavy metals panel (arsenic, lead, mercury) | Blood |
| Serum drug screen (acetaminophen, salicylates, tri-cyclic antidepressants, ethyl alcohol) | Blood |
| Domain | Examples from patient presentation during episodes |
|---|---|
| Delusions | Paranoia delusions – religious repenting/guilt; food contamination |
| Hallucinations | Tactile hallucinations (bug on back) |
| Disorganized speech | Delayed/severely restricted/non-responsive speech, tangential speech |
| Grossly disorganized motor behavior | Catatonia, rigidity/immobility, posturing, echolalia |
| Negative symptoms | Decreased emotional expressions, flat affect |